10 January, 2025Mediar Therapeutics enters into global licensing agreement with Lilly to advance first-in-class WISP1 antibody for the treatment of idiopathic pulmonary fibrosis (IPF)
9 January, 2025Global debut in an ASC setting at Surgeon's Point Surgery Center for Moon Surgical's Maestro System
9 January, 2025Tenpoint Therapeutics announces positive topline data from Phase 3 pivotal study, BRIO-II, of BRIMOCHOL™ PF for the treatment of presbyopia
9 January, 2025Bon Vivant achieves self-affirmed GRAS status, notifying the FDA of its recombinant whey protein enabling commercialization in the U.S.